703
Participants
Start Date
February 28, 2020
Primary Completion Date
February 1, 2027
Study Completion Date
February 1, 2027
pembrolizumab
IV infusion
placebo
IV infusion
cisplatin
IV infusion
5-FU
IV infusion
radiotherapy
external radiation
leucovorin
IV infusion
levoleucovorin
IV infusion
oxaliplatin
IV infusion
Taichung Veterans General Hospital-Radiation Oncology ( Site 0647), Taichung
Chang Gung Med Foundation. Kaohsiung Branch ( Site 0643), Kaohsiung City
St. Luke s Medical Center ( Site 0601), Quezon City
Orszagos Onkologiai Intezet ( Site 0263), Budapest
UCL Saint Luc ( Site 0162), Brussels
Rigshospitalet ( Site 0199), Copenhagen
Baguio General Hospital and Medical Center ( Site 0603), Baguio City
UZ Leuven ( Site 0161), Leuven
Debreceni Egyetem Klinikai Kozpont ( Site 0261), Debrecen
Odense Universitetshospital ( Site 0200), Odense
The Medical City-Iloilo ( Site 0602), Iloilo City
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 0262), Gyula
Cebu Doctors University Hospital ( Site 0604), Cebu City
Pecsi Tudomanyegyetem AOK ( Site 0265), Pécs
AZ Delta ( Site 0165), Roeselare
UZ Gent ( Site 0163), Ghent
National Taiwan University Hospital ( Site 0641), Taipei
Weill Cornell Medical College ( Site 0053), New York
National Cancer Center ( Site 0626), Goyang-si
Koo Foundation Sun Yat-Sen Cancer Center ( Site 0644), Taipei
Charite Campus Virchow Klinikum ( Site 0250), Berlin
SA Pohja-Eesti Regionaalhaigla ( Site 0201), Tallinn
Centre Francois Baclesse ( Site 0236), Caen
Detecta Clínica ( Site 0146), Surquillo
Hospital Nacional Arzobispo Loayza ( Site 0143), Lima
Clinica San Gabriel ( Site 0142), Lima
Allegheny Health Network ( Site 0042), Pittsburgh
IRCCS Policlinico San Donato ( Site 0295), San Donato Milanese
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0292), Milan
Facharztzentrum Eppendorf ( Site 0242), Hamburg
Centre Georges Francois Leclerc ( Site 0223), Dijon
Greater Baltimore Medical Center ( Site 0031), Baltimore
ASST Papa Giovanni XXIII ( Site 0296), Bergamo
Azienda Socio Sanitaria Territoriale di Cremona ( Site 0299), Cremona
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 0300), Pavia
Columbus Regional Research Institute ( Site 0047), Columbus
Chang Gung Medical Foundation. Linkou ( Site 0642), Taoyuan District
Istanbul University Cerrahpasa Medical Faculty ( Site 0452), Istanbul
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0451), Istanbul
Ege Universitesi Tip Fakultesi ( Site 0457), Izmir
IRCCS Istituto Oncologico Veneto ( Site 0298), Padua
Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma Hastanesi ( Site 0458), Izmir
Thompson Cancer Survival Center ( Site 0696), Knoxville
China Medical University Hospital ( Site 0646), Taichung
CHU Hotel Dieu Nantes ( Site 0230), Nantes
Universitaetsklinikum Muenster ( Site 0248), Münster
Henry Ford Hospital ( Site 0685), Detroit
CENTRO HEMATO ONCOLOGICO PRIVADO-CHOP ( Site 0728), Toluca
SA Tartu Ulikooli Kliinikum ( Site 0202), Tartu
Universitaetsklinikum Koeln ( Site 0251), Cologne
University of Wisconsin Hospital and Clinics ( Site 0033), Madison
Institut De Cancerologie De Lorraine ( Site 0222), Vandœuvre-lès-Nancy
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz ( Site 0247), Mainz
Azienda Ospedaliero Universitaria Pisana - Presidio Santa Chiara ( Site 0294), Pisa
Chonnam National University Hwasun Hospital ( Site 0625), Hwasun Gun
University of Missouri ( Site 0688), Columbia
University of Kansas Cancer Center ( Site 0023), Westwood
Cancer Center of Kansas ( Site 0058), Wichita
University Medical Center ( Site 0035), New Orleans
Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0253), Stuttgart
National Cheng Kung University Hospital ( Site 0645), Tainan City
Stephenson Cancer Center ( Site 0044), Oklahoma City
CHU Amiens Picardie Site Sud Amiens ( Site 0235), Amiens
Istituto Nazionale Tumori IRCCS Fondazione Pascale-SC Oncologia Clinica Sperimentale Addome ( Site 0, Napoli
Utah Cancer Specialists ( Site 0697), Salt Lake City
Institut Sainte Catherine ( Site 0228), Avignon
CHD Vendee ( Site 0227), La Roche-sur-Yon
CHU Limoges Hopital Dupuytren ( Site 0225), Limoges
Renown Regional Medical Center ( Site 0706), Reno
MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691), Long Beach
Institut Curie - Centre Rene Huguenin ( Site 0237), Saint-Cloud
Oregon Health & Science University Center for Health & Healing 2- CHH2 ( Site 0060), Portland
Cancer Care Northwest - Spokane Valley ( Site 0036), Spokane Valley
Main Military Clinical Hospital n.a. N.N.Burdenko ( Site 0421), Moscow
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 0429), Moscow
Pavlov First Saint Petersburg State Medical University ( Site 0426), Saint Petersburg
Medical institute named after Berezin Sergey ( Site 0417), Saint Petersburg
Shanghai Chest Hospital ( Site 0501), Shanghai
Shanghai Chest Hospital ( Site 0503), Shanghai
Zhongshan Hospital Fudan University ( Site 0502), Shanghai
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0394), Craiova
Jiangsu Cancer Hospital ( Site 0519), Nanjing
Affiliated Hospital of Jiangsu University ( Site 0524), Zhenjiang
The Affiliated Hospital of Xuzhou Medical University ( Site 0522), Xuzhou
Huai an First People s Hospital ( Site 0526), Huai'an
Anhui Provincial Hospital-Oncology Radiotherapy Department ( Site 0531), Hefei
Kaluga Regional Clinical Oncology Center ( Site 0424), Kaluga
Tianjin Medical University Cancer Institute & Hospital ( Site 0505), Tianjin
Hangzhou First People's Hospital ( Site 0530), Hangzhou
Sir Run Run Shaw Hospital ( Site 0523), Hangzhou
Zhejiang Cancer Hospital ( Site 0529), Hangzhou
Jiangxi Cancer Hospital ( Site 0512), Nanchang
The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army ( Si, Fuzhou
The First Affiliated Hospital of Xiamen University ( Site 0538), Xiamen
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0392), Cluj-Napoca
S.C. Radiotherapy Center Cluj S.R.L ( Site 0391), Cluj-Napoca
Hunan Cancer Hospital ( Site 0515), Changsha
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0412), Kazan'
Hubei Cancer Hospital ( Site 0514), Wuhan
SBHI Samara Regional Clinical Oncology Dispensary ( Site 0420), Samara
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 0430), Ufa
Centrul Medical Topmed ( Site 0398), Târgu Mureş
Sichuan Cancer Hospital ( Site 0527), Chengdu
Sverdlovsk Regional Oncology Hospital ( Site 0411), Yekaterinburg
Ovidius Clinical Hospital OCH-Oncology and Hematology ( Site 0393), Ovidiu
National Cancer Center Hospital East ( Site 0562), Kashiwa
Hospital Regional de Concepcion ( Site 0105), Concepción
Centro Investigación del Cáncer James Lind ( Site 0106), Temuco
Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 0103), Temuco
Centro de Cancer Nuestra Senora de la Esperanza ( Site 0104), Santiago
Dana Farber Cancer Center ( Site 0034), Boston
Rutgers Cancer Institute of New Jersey ( Site 0695), New Brunswick
Instituto Medico Alexander Fleming ( Site 0063), Buenos Aires
Fundacion Favaloro ( Site 0061), Ciudad de Buenos Aires
Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0066), Buenos Aires
CEMIC ( Site 0064), Buenos Aires
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 0088), Ijuí
Hospital Nossa Senhora da Conceicao ( Site 0087), Porto Alegre
Clinica de Oncologia Reichow ( Site 0085), Blumenau
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0081), São Paulo
Cross Cancer Institute ( Site 0010), Edmonton
CancerCare Manitoba ( Site 0002), Winnipeg
The Ottawa Hospital - Cancer Care ( Site 0008), Ottawa
Sunnybrook Research Institute ( Site 0012), Toronto
Princess Margaret Cancer Centre ( Site 0011), Toronto
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0005), Montreal
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0721), Brno
Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 0719), Ostrava
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0720), Olomouc
Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0718), Prague
Institut Jean Godinot ( Site 0238), Reims
Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0122), Guatemala City
Gastrosoluciones ( Site 0126), Guatemala City
Oncomedica ( Site 0125), Guatemala City
Grupo Medico Angeles ( Site 0121), Guatemala City
Medi-K Cayala ( Site 0124), Guatemala City
Centro Medico Integral De Cancerología (CEMIC) ( Site 0123), Quetzaltenango
Pamela Youde Nethersole Eastern Hospital ( Site 0543), Hong Kong
Princess Margaret Hospital. ( Site 0542), Hong Kong
Queen Mary Hospital ( Site 0541), Pokfulam
Policlinico Universitario A. Gemelli ( Site 0297), Roma
Aichi Cancer Center Hospital ( Site 0563), Nagoya
Kanagawa Cancer Center ( Site 0565), Yokohama
Saitama Cancer Center ( Site 0564), Kitaadachi-gun
Shizuoka Cancer Center Hospital and Research Institute ( Site 0566), Sunto-gun
National Cancer Center Hospital ( Site 0561), Tokyo
Cryptex Investigación Clínica S.A. de C.V. ( Site 0729), Cuauhtémoc, Ciudad de México
Instituto Nacional de Enfermedades Neoplasicas ( Site 0141), Lima
Hospital Beatriz Angelo ( Site 0374), Loures
Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE ( Site 0372), Lisbon
Hospital da Luz ( Site 0373), Lisbon
CHLN Hospital Santa Maria ( Site 0376), Lisbon
Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 0371), Porto
MedEuropa Bucuresti - Centru de Radioterapie-Oncology ( Site 0400), Bucharest
S.C.Focus Lab Plus S.R.L ( Site 0395), Bucharest
Asan Medical Center ( Site 0623), Songpagu
Severance Hospital Yonsei University Health System ( Site 0624), Seoul
Samsung Medical Center ( Site 0622), Seoul
Korea University Guro Hospital ( Site 0621), Seoul
Memorial Ankara Hastanesi ( Site 0461), Ankara
Aberdeen Royal Infirmary ( Site 0474), Aberdeen
Cambridge University Hospitals NHS Trust ( Site 0477), Cambridge
Royal Free Hospital ( Site 0702), London
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 0283), London
Hammersmith Hospital-Medical Oncology ( Site 0471), London
Nottingham University Hospitals NHS Trust ( Site 0476), Nottingham
Royal Marsden Hospital (Sutton) ( Site 0281), Sutton
University College Hospital NHS Foundation Trust ( Site 0701), London
The Christie NHS Foundation Trust ( Site 0282), Manchester
Mount Vernon Hospital ( Site 0478), Northwood
Merck Sharp & Dohme LLC
INDUSTRY